Multiple myeloma patient study shows promise for natural killer cells

(University of Texas M. D. Anderson Cancer Center) A first-in-human Phase I study of multiple myeloma patients combined expanded cord blood-derived natural killer cells with transplantation of a patient's own stem cells and high-dose chemotherapy with little or none of the side effects seen with current treatments.